LCNDG Rapid Review: Abiraterone for the treatment of metastatic castration-resistant prostate cancer that has progressed on or after a docetaxel-based chemotherapy regimen
Source: London Cancer New Drugs Group Area: Evidence #62; Drug Specific Reviews Although there is currently no standard treatment for patients with metastatic CRPC who progress following docetaxel, palliative options currently used include mitoxantrone with or without steroids, and best supportive care.#160; Newer agents are being trialled in this setting and the taxane derivative cabazitaxel was recently licensed, a Phase III study demonstrating that it increased median overall survival by 2.4 months compared to mitoxantrone (both in combination with prednisone/prednisolone).#160;#160;#160;#160; #160; Abiraterone acetate has been approved by the European Medicines Agency for use in combination with prednisone/prednisolone for the treatment of metastatic CRPC in adult men whose...

Heartland Health Joins Mayo Clinic Care Network
Mayo Clinic today announced Heartland Health, based in St. Joseph, MO., is joining the Mayo Clinic Care Network. (Source: News from Mayo Clinic)div id=medwormpbiMedWorm Sponsor Message:/i/b Have a look at a href=http://www.thepsychologydaily.comThe Psychology Daily/a, the new psychology portal powered by MedWorm, with all the latest psychology news and research updated daily./p/div